Bugiardini Raffaele, Manfrini Olivia, De Ferrari Gaetano M
Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Italy.
Arch Intern Med. 2006 Jul 10;166(13):1391-5. doi: 10.1001/archinte.166.13.1391.
The prognostic implication of chest pain associated with normal or near-normal findings on angiography is still unknown. We explored outcomes and methods of risk stratification in patients with nonobstructive coronary artery disease in the setting of non-ST-segment elevation acute coronary syndromes.
Data were pooled from 3 Thrombolysis in Myocardial Infarction (TIMI) trials (TIMI 11B, TIMI 16, and TIMI 22). Angiographic data were available on 7656 patients with non-ST-segment elevation acute coronary syndromes. The primary end point of this analysis was the composite of the rates of death, myocardial infarction, unstable angina requiring rehospitalization, revascularization, and stroke at 1-year follow-up. Outcomes were evaluated by mean of the TIMI risk score for developing at least 1 component of the primary end point.
Angiographic findings showed that 710 (9.1%) of 7656 patients had nonobstructive coronary artery disease; 48.7% of these had normal coronary arteries (0% stenosis), and 51.3% had mild coronary artery disease (>0% to <50% stenosis). A primary end-point event occurred in 101 patients (12.1%). It is noteworthy that a 2% event rate of deaths and myocardial infarctions had occurred in these patients at the 1-year follow-up. Event rates of death and myocardial infarction increased significantly as the TIMI risk score increased from 0.6% for a score of 1 to 4.0% for a score greater than 4.
Patients with non-ST-segment elevation acute coronary syndromes with nonobstructive coronary artery disease detected by angiography have a substantial risk of subsequent coronary events within 1 year. The risk is not univariately high, and the TIMI risk score helps to reveal patients at high risk.
血管造影显示正常或接近正常时胸痛的预后意义仍不明确。我们探讨了非ST段抬高型急性冠状动脉综合征患者中无阻塞性冠状动脉疾病患者的预后及风险分层方法。
数据来自3项心肌梗死溶栓治疗(TIMI)试验(TIMI 11B、TIMI 16和TIMI 22)。7656例非ST段抬高型急性冠状动脉综合征患者有血管造影数据。该分析的主要终点是1年随访时死亡、心肌梗死、需再次住院的不稳定型心绞痛、血运重建和卒中发生率的复合终点。通过TIMI风险评分来评估发生至少1个主要终点组成部分的结局。
血管造影结果显示,7656例患者中有710例(9.1%)患有无阻塞性冠状动脉疾病;其中48.7%的患者冠状动脉正常(狭窄0%),51.3%的患者患有轻度冠状动脉疾病(狭窄>0%至<50%)。101例患者(12.1%)发生了主要终点事件。值得注意的是,在1年随访时,这些患者中死亡和心肌梗死的发生率为2%。随着TIMI风险评分从1分的0.6%增加到大于4分的4.0%,死亡和心肌梗死的发生率显著增加。
血管造影检测到无阻塞性冠状动脉疾病的非ST段抬高型急性冠状动脉综合征患者在1年内有发生后续冠状动脉事件的重大风险。该风险并非单一地高,TIMI风险评分有助于发现高危患者。